Suspected cancer

Publication date:

Suspected cancer
 
Status
In progress
Publication date
May 2015
Process
CG
Topic area
  • Cancer
  • Diagnostic procedures

Provisional Schedule

Scoping workshop: 19 March 2012
Consultation on draft scope with stakeholders: 3 April 2012 - 30 April 2012
Consultation on draft guideline with stakeholders: 20 November 2014 ? 9 January 2015
Publication date: May 2015

Project Team

Centre for clinical practice lead: Christine Carson
Guidelines commissioning manager:

Katie Perryman-Ford

Guidelines coordinator: Jennifer Watson-Henry
Patient involvement lead: Barbara Meredith
Implementation lead: Katie Perryman-Ford
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.

Email enquiries

Timeline

Date
Update
30 June 2012

The National Collaborating Centre/Internal Development team may make a focussed call for evidence on specific clinical questions or sub-questions after completing its initial searches. It is able to make a call for evidence at any point during development of the guideline and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence.

The National Collaborating Centre/Internal Development team may not issue any calls for evidence for a guideline if the Guideline Development Group feels it is not necessary. In addition, the National Collaborating Centre/Internal Development team will accept relevant confidential data for consideration by the Guideline Development Group. The Health Economic plan, review questions and search strategies will be available on the website 5 weeks prior to the draft guideline consultation commencing.

15 June 2012
The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table .The Guideline Development Group (GDG) oversees the development process.
3 April 2012
The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
Get involved